Código QR (código de barras bidimensional)

Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database

IntroductionCyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are first-line treatments for hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer. With their increasing clinical use, infection-related adverse events (AEs) associated with CDK4/6 inhibitors have b...

ver descrição completa

Na minha lista:
Principais autores: Jinhua Chen, Linlin Tang, Wenping Song, Cuicui Sun, Wenzhou Zhang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2024-07-01
coleção:Frontiers in Pharmacology
Assuntos:
CDK4/6 inhibitor
FAERS
infection
adverse events
ribociclib
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2024.1371346/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados